Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
May 15, 2014
May 13, 2014
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
May 12, 2014
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
May 08, 2014
UCSF Medical Center has the highest one-year survival rate in the nation, among institutions performing more than 20 adult lung transplants each year, according to data from the Scientific Registry of Transplant Recipients.
May 08, 2014
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
May 07, 2014
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
May 06, 2014
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
May 05, 2014
The Food and Drug Administration has selected UCSF as the site of a new regulatory science center on the West Coast. The center aims to spur innovative approaches in drug development that will support the FDA’s ability to evaluate and approve safe and effective new medications.
May 02, 2014
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
April 30, 2014
New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers.